My TransOvaLog In
Aug 13, 2024
Recent data from the Brazilian Association of Artificial Insemination (Asbia) indicates that more than 538,000 embryos were produced in the country in 2022 alone. Of this total, around 340,000 were destined for beef cattle, while just over 161,000 were destined for dairy cattle. It is within this scenario that Trans Ova, a U.S.-based company in this segment, announces its arrival in Brazil.
The second largest embryo market in the world, according to a study by Embrapa researchers, Brazil is only behind the United States in production volume.
“We will begin our operations in September, in one of the largest and most important markets on the planet. We will bring all our expertise to the Brazilian market, and we are sure that we will have a very successful journey here,” comments Kevin Hoogendoorn, CEO of Trans Ova.
According to Hoogendoorn, Trans Ova is the company that invests the most in research in this market on a global scale, and therefore, it is also the player that is best able to potentialize the production of embryos in the country.
“The supply of embryos in the national market will increase consistently with our arrival, since we will have the capacity to meet the demand and provide above-average results for ranchers.”
The company is the most technologically advanced bovine reproductive company in the U.S.
“Trans Ova has laboratories and equipment that bring together the most modern ideas in the world, in the area of livestock genetics and reproduction,” he concludes.
In Brazil, the company’s expectations are quite positive. Through its industry-leading reproductive technologies and its focus on providing clients with an incredible experience Trans Ova expects to achieve high levels of success in the Brazil market.
The technicians and veterinarians of Trans Ova who will work in Brazil have undergone training in the USA, even accompanying the procedures carried out by American veterinarians on customer farms.
Since 2022, the company has belonged to the Urus Group, a world leader in bovine genetic improvement. In Brazil, Urus owns companies that work with bovine genetic improvement, such as Alta Genetics and Genex Brasil.
The initial operation of Trans Ova will contemplate the production of embryos, while the commercialization will be the responsibility of companies like Alta Genetics, initially its main client.
In beef cattle, the use of embryos aims to improve feed efficiency, weight gain and carcass quality. Embryo transfer is widely used to disseminate desirable genetic characteristics, quickly and consistently.
In dairy cattle, the use aims to improve productivity, milk quality, longevity and herd health. Thus, embryo production is used essentially to maximize milk production and improve reproductive efficiency.
Headquartered in the USA and founded in 1980, Trans Ova Genetics provides industry-leading reproductive technologies for breeders seeking to advance and amplify superior genetics. The company helps multiply the genetic success of a herd.
Reproductive technologies, such as embryo transfer, In Vitro Fertilization (IVF), sexed semen, genetic preservation and cloning are considered excellent reproductive tools for breeders seeking to achieve specific breeding and reproduction goals.
Recognized internationally as a source of superior experience in animal breeding and reproduction, Trans Ova Genetics offers an integrated system of regional centers, satellite centers and application of reproductive technologies on farms.
To learn more about Trans Ova Genetics in Brazil, visit https://www.transova.com.br